Skip to main content
XTNT logo

XTNT · Xtant Medical Holdings, Inc. · Executive Compensation

Track XTNT — free
$0.35 0.00 (-0.25%)
Market Cap
$52.02M
Shares
140.29M
Volume · Oct 1 36.85K Avg daily vol (3M) 1.69M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
Sean Browne $1,351,676
Sean E. Browne $1,351,676
Mark A. Schallenberger $1,110,531
Scott C. Neils $939,369
Scott Neils $939,369
Fiscal 2024
Executive Total
Sean E. Browne $2,461,736
Sean Browne $2,461,736
Kevin D. Brandt $1,230,700
Scott Neils $883,507
Scott C. Neils $883,507
Mark A. Schallenberger $878,961
Fiscal 2023
Executive Total
Sean E. Browne $1,712,158
Sean Browne $1,712,158
Mark A. Schallenberger $1,174,623
Kevin D. Brandt $947,369
Scott C. Neils $937,853
Scott Neils $937,853
Fiscal 2022
Executive Total
Sean Browne $1,060,562
Sean E. Browne $1,060,562
Kevin D. Brandt $778,496
Scott C. Neils $766,533
Scott Neils $766,533
Fiscal 2021
Executive Total
Chief Commercial $924,016
Sean E. Browne $831,490
Sean Browne $831,490
Fiscal 2020
Executive Total
Sean E. Browne $4,549,054
Sean Browne $4,549,054
Greg Jensen $861,104
Kevin D. Brandt $821,355
Fiscal 2019
Executive Total
Sean E. Browne $1,852,264
Sean Browne $1,852,264
Kevin D. Brandt $812,266
Greg Jensen $689,194

Executive changes

Person Change Filed
Stavros G. Vizirgianakis Appointed 2025-11-10
Tyler P. Lipschultz Appointed 2025-11-10
Sean E. Browne Appointed 2025-11-10
Abhinav Jain Appointed 2025-11-10
Jonn R. Beeson Appointed 2025-11-10
John K. Bakewell Appointed 2025-11-10
Lori Mitchell-Keller Resigned 2025-08-04
Tyler Lipschultz Appointed 2025-08-04
Robert McNamara Resigned 2025-08-04
Abhinav Jain Appointed 2025-08-04
Lori D. Mitchell-Keller Appointed 2023-05-18
Matthew Rizzo Resigned 2023-05-04
Michael Eggenberg Resigned 2023-05-04
Jonn R. Beeson Appointed 2023-05-04
Mark Schallenberger Appointed 2023-01-09
Mark A. Schallenberger Appointed 2023-01-09
Stavros G. Vizirgianakis Appointed 2022-08-31
Stavros G. Vizirgianakis Appointed 2022-08-31
Stavros Vizirgianakis Appointed 2022-08-31
Stavros Vizirgianakis Appointed 2022-08-31
Stavros G. Vizirgianakis Appointed 2022-08-24
Key facts CIK 1453593 CUSIP 98420P308 13F (30d) 2 filings 2 filers Visit website Investor relations